Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

X4 Pharmaceuticals (XFOR) Shares Issued (2019 - 2025)

Historic Shares Issued for X4 Pharmaceuticals (XFOR) over the last 7 years, with Q3 2025 value amounting to $86.9 million.

  • X4 Pharmaceuticals' Shares Issued changed N/A to $86.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $87.1 million, marking a year-over-year increase of 3666666.67%. This contributed to the annual value of $294000.0 for FY2024, which is 9662.53% down from last year.
  • As of Q3 2025, X4 Pharmaceuticals' Shares Issued stood at $86.9 million.
  • Over the past 5 years, X4 Pharmaceuticals' Shares Issued peaked at $86.9 million during Q3 2025, and registered a low of $2000.0 during Q3 2023.
  • Over the past 5 years, X4 Pharmaceuticals' median Shares Issued value was $103000.0 (recorded in 2021), while the average stood at $9.7 million.
  • Over the last 5 years, X4 Pharmaceuticals' Shares Issued had its largest YoY gain of 4683.54% in 2021, and its largest YoY loss of 5729.17% in 2021.
  • Over the past 5 years, X4 Pharmaceuticals' Shares Issued (Quarter) stood at $103000.0 in 2021, then soared by 33.98% to $138000.0 in 2022, then fell by 29.71% to $97000.0 in 2023, then soared by 39.18% to $135000.0 in 2024, then surged by 64274.07% to $86.9 million in 2025.
  • Its Shares Issued was $86.9 million in Q3 2025, compared to $135000.0 in Q4 2024 and $97000.0 in Q4 2023.